Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
2005 1
2008 1
2009 4
2010 2
2012 1
2013 2
2014 1
2015 1
2017 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Twenty-year-old female with leiomyosarcoma of the breast.
Bassett P, Shaban J, Fulger I, Petersen B. Bassett P, et al. Among authors: shaban j. J Surg Case Rep. 2014 Jan 10;2014(1):rjt121. doi: 10.1093/jscr/rjt121. J Surg Case Rep. 2014. PMID: 24876324 Free PMC article.
Cardiac pheochromocytoma presenting during pregnancy.
Fraser LA, Kiaii B, Shaban J, Islam A, Diamantouros P, Jones PM, Tweedie E, Varghese R, Van Uum S. Fraser LA, et al. Among authors: shaban j. BMJ Case Rep. 2010 Oct 21;2010:bcr0420102890. doi: 10.1136/bcr.04.2010.2890. BMJ Case Rep. 2010. PMID: 22791480 Free PMC article.
Predictors of postprandial blood glucose response to biphasic insulin analogue therapy.
Borzì V, Benroubi M, Gumprecht J, Kawamori R, Ligthelm R, Shaban J, Shah S, Shestakova M, Wenying Y, Valensi P; IMPROVE™ Study Expert Panel. Borzì V, et al. Among authors: shaban j. Prim Care Diabetes. 2013 Apr;7(1):63-7. doi: 10.1016/j.pcd.2012.09.002. Epub 2012 Nov 20. Prim Care Diabetes. 2013. PMID: 23182405
The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts.
Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y; IMPROVE Study Group Expert Panel. Valensi P, et al. Among authors: shaban j. Int J Clin Pract. 2008 Nov;62(11):1809-19. doi: 10.1111/j.1742-1241.2008.01917.x. Epub 2008 Sep 22. Int J Clin Pract. 2008. PMID: 18811598 Clinical Trial.
Predictors of achieving HbA(1c) <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study.
Valensi P, Shaban J, Benroubi M, Kawamori R, Borzì V, Shah S, Wenying Y, Prusty V, Hansen JB, Gumprecht J; IMPROVE Study Expert Panel. Valensi P, et al. Among authors: shaban j. Curr Med Res Opin. 2013 Jun;29(6):601-9. doi: 10.1185/03007995.2013.786692. Epub 2013 Apr 12. Curr Med Res Opin. 2013. PMID: 23488447
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study.
Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shestakova M, Wenying Y, Valensi P; IMPROVE Study Group Expert Panel. Shah S, et al. Among authors: shaban j. Int J Clin Pract. 2009 Apr;63(4):574-82. doi: 10.1111/j.1742-1241.2009.02012.x. Epub 2009 Feb 5. Int J Clin Pract. 2009. PMID: 19210701 Free PMC article. Clinical Trial.
15 results